Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        About Science & Research at FDA

FDA Grand Rounds Home
          Science & Research
          About Science & Research at FDA
          FDA Grand RoundsAbout Science & Research at FDA FDA Grand Rounds
  	
        Share
    Post
    Linkedin

    Email
    PrintFDA Grand Rounds
The FDA Grand Rounds is an educational presentation that is webcast monthly to highlight cutting-edge research underway across the Agency and its impact on protecting and advancing public health. Each session features an FDA scientist presenting on a key public health challenge and how FDA is applying science to its regulatory activities. The 45-minute educational presentation is followed by questions from the audience. You can also view the presentation under Past Grand Rounds following the live webcast. **#FDAGrandRounds.**

Upcoming Event

**FDA Grand Rounds: Copper in Dog Food: A Case Study in Reconciling Nutritional & Regulatory Science**

Thursday, February 8, 2024
12:00 p.m. - 1:00 p.m. ET
Webcast

About the Speaker

Karen L. Donnelly, D.V.M., M.S.
Veterinary Medical Officer
Division of Animal Food Ingredients
Office of Surveillance and Compliance
Center for Veterinary Medicine

Dr. Donnelly’s work at CVM involves conducting pre-market review of new ingredients for use in pet food and providing guidance to state feed regulators, industry groups, and companies on regulatory matters pertaining to pet food.  She worked as a small animal veterinarian in the DC metro region prior to joining CVM in 2018. She holds a DVM from the Virginia-Maryland College of Veterinary Medicine, an M.S. from the University of Miami, and a B.S. from Cornell University.

Past Grand Rounds

2024

**The Real Cost Campaign: A Decade of Preventing Youth Tobacco Use**2023

**FDA Approach to the Safety Assessment of Food Ingredients**
	**5G Connectivity in Medical Devices: Landscape, Knowledge Gaps, and Regulatory Science Research**
	**Applied Regulatory Research to Address the Ongoing Opioid Crisis**
	**Acquisition of Host Iron by Corynebacterium diphtheriae: Iron-Regulated Surface Factors as Possible Vaccine Candidates**
	**The Plasmid Puzzle: Finding Solutions in Salmonella**
	**FDA’s Global Substance Registration System (GSRS) Unique Ingredient Identifiers (UNIIs) uniquely define substances in FDA-regulated products**
	**Electron Microscopy, Still a Powerful Research Tool**
	**Identification of Persistent Organic Pollutants in Foods: Method Development and Automation**
	**Microphysiological Systems as Novel Disease Models and Drug Development Tools**
	**A Modular Approach for Enhanced Plasmid Subtyping and AMR Gene Profiling of Plasmids**
	**The Scientific Basis of Proposed Tobacco Product Standards to Prohibit Menthol as a Characterizing Flavor in Cigarettes and Flavors in Cigars**2022

**Wastewater Surveillance for SARS-CoV-2 Variants: a pandemic response project leveraging FDA’s GenomeTrakr network**
	**Medical Extended Reality: Applications and Challenges**
	**Quality Considerations for the Multi-Attribute Method (MAM) for Therapeutic Proteins**
	**Polio Vaccines: Past, Present, and the Future**
	**One Health at FDA: From Concept to Application**
	**Some Perspectives on Data Science and Coronaviruses**
	**The Saga of Phosphatidylinositol 3-Kinase (PI3K) Inhibitors**
	**MinION Sequencing of Foodborne Pathogens**
	**An Overview of Tattoo Ink Research at the National Center for Toxicological Research**
	**Challenges in Predicting the Environmental Exposure Concentration of Terrestrial Animal Drugs**
	**Development and Testing of Warnings for Tobacco Products: Scientific and Regulatory Considerations**2021

**Closer to Zero**
	**The Development of Cellular-Level Structural and Functional Biomarkers of Eye Disease Enabled by Adaptive Optics**
	**Laboratory and Clinical Studies to Investigate Whether Ranitidine Converts to a Probable Carcinogen in Humans**
	**Immune System Responses to Therapeutic Proteins: Getting up close and personal**
	**SARS-CoV-2: Host-pathogen interaction, vaccines & variants of concern**
	**FDA's work with African Swine Fever from a policy and regulatory perspective**
	**Project Orbis: Global Collaborative Oncology Review Program**
	**Electrical Safety in CTP Regulated Products**
	**Studies of SARS-CoV-2 NSP1 and Envelope Protein**
	**Research and Development of Radioanalytical Capabilities for Detection of Radionuclides in Food**
	**FDA Grand Rounds: The CORE Network (or How I Learned to Love Lettuce...)**2020

**Assessment of Safety and Efficacy of Fecal Microbiota for Transplantation Products**
	**Facial Coverings During the COVID-19 Pandemic: How well do they flatten the curve?**
	**Bioequivalence of Complex Topical Generics: In Vitro and In Vivo**
	**Advancing the Science of Real-World Data to Address the COVID-19 Pandemic**
	**Nanotechnology: Over a Decade of Progress and Innovation at FDA**
	**A Pandemic and a Call to Action for One Health: The FDA One Health Initiative**
	**Artificial Intelligence for Regulatory Science Research**
	**Analysis of Per and Polyfluoroalkyl Substances (PFAS) in foods- Analytical method development, challenges and successes**
	**Modernization of Pharmaceutical Manufacturing through the Adoption of Advanced Technology**
	**Detection of Transmissible Spongiform Encephalopathy Agents in Biological Products Using Protein Aggregation Assays**
	**Quality Control: Stopping infections before they happen through safer endoscope reprocessing**2019

**Vet-LIRN – How FDA’s Network of Veterinary Diagnostic Laboratories advance animal food safety and public health by conducting outbreak investigations and monitoring resistance in animal pathogens** [Archived]
	**Technical and Logistical Considerations for Examining FDA-Regulated Products at International Mail Facilities using Handheld and Field-Portable Analytical Devices** [Archived]
	**Why FDA authorized the marketing of the IQOS heated tobacco product as “appropriate for the protection of the public health”** [Archived]
	**Overview of FDA's Perinatal Health Center of Excellence: Development and Validation of Predictive Systems** [Archived]
	**Cyclospora Cayetanensis: The Crossroads Between Scientific Advances and Knowledge Gaps** [Archived]
	**Gaining Insight into the Patient’s Experience by Harnessing the Power of Social Listening and FDA Archival Data** [Archived]
	**Uncertainty is the only certainty there is: Potential approaches for making public health decisions** [Archived]
	**The VICTRE trial: an in-silico replica of a clinical trial for evaluating digital breast tomosynthesis as a replacement for full-field digital mammography** [Archived]2018

**Jerky Pet Treats and illness in dogs:  a collaborative approach to investigating a mysterious outbreak** [Archived]
	**Decomposition of Seafood Products by Mass Spectrometry with Sensory-Driven Predictive Modeling** [Archived]
	**The Science to Inform a Tobacco Product Standard for the Level of Nicotine in Combusted Cigarettes** [Archived]
	**Bisphenol A: Toxicology and Pharmacokenetic Data to Inform Ongoing Safety Assessments** [Archived]
	**How Simulation Can Transform Regulatory Pathways** [Archived]
	**FDA's Predictive Toxicology Roadmap: Implications and Opportunities for Stakeholders** [Archived]
	**Are Stem Cells Ready for Prime Time? A Look at FDA Research Advances in Regenerative Medicine** [Archived]
	**Ethnicity- and Gender-Related Differences in Alzheimer's Disease** [Archived]2017

**Assessing the Safety and Effectiveness of New and Emerging Therapeutic Ultrasound Technologies** [Archived]
	**Developing a Mechanistic Model-Based Approach to Assess Cardiac Safety of New Drugs** [Archived]
	**Genome Trakr: How a Large Network of Sequencing Laboratories is Transforming Food Safety and Public Health** [Archived]
	**Serious and Actionable Risks, Plus Disclosure: investigating an Alternative Approach for Presenting Risk Information in Prescription Drug TV Ads** [Archived]
	**Vaccine adjuvants: New ways to evaluate their safety and effectiveness** [Archived]
	**Developing Regulatory Methods for Characterizing Nanomaterials in FDA-Regulated Products** [Archived]2016

**The Host Response to Whooping Cough Infection and Vaccination**External Link Disclaimer [Archived]
	**Antibiotic resistance surveillance in the age of genomics: New answers to old questions**External Link Disclaimer [Archived]
	**FDA Research into 3D Printing of its Regulated Products**External Link Disclaimer [Archived]
	**Rapid Screening of Dietary Supplements for Undeclared Ingredients**External Link Disclaimer [Archived]
	**Metabolomics and Proteomics Biomarkers: Discovery and Validation in Toxicity StudiesExternal Link Disclaimer**[Archived]Resources For You

FDA's Predictive Toxicology Roadmap
	Don't Miss the CDC Public Health Grand RoundsSub-Topic Paragraphs
          Latest From the CommissionerLa FDA autoriza programa de importación de medicamentos en Florida
	Jan 05Remarks by Commissioner Robert Califf to the National Consumer League Health Advisory Council Winter Meeting - 11/29/2023
	Nov 30Remarks by FDA Commissioner Robert Califf at the Reagan Udall Public Meeting on Front of Package Labeling - 11/16/2023
	Nov 16Remarks by Commissioner Robert Califf to the Association of Professors of Medicine (APM) - 11/15/2023
	Nov 15Remarks by Commissioner Robert Califf to the Healthcare Distribution Alliance Board of Directors meeting - 11/15/2023
	Nov 15Remarks by Dr. Robert Califf on the Reagan Udall Foundation's report and recommendations on Evidence Generation - 11/14/2023
	Nov 14FDA Proposes to Ban Food Additive, Continues Assessments of Additional Chemicals
	Nov 02FDA Deputy Commissioner for Human Foods Commits to Fulfilling Vision of Proposed Program
	Oct 19

                                                                                  Content current as of:
      01/17/2024FDA Grand Rounds
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop